PCN64 - Budget Impact Analysis of Regorafenib for The Treatment in Third and Fourth Lines of Metastasic Colorectal Cancer in Spain

Autor: González Flores, E, Vera García, R, Sabater Cabrera, E, Tirado Mercier, E, Granell Villalon, M
Zdroj: In Value in Health November 2016 19(7):A719-A720
Databáze: ScienceDirect